Polymarket Market
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Upcoming
- Probability
- 64%
- Liquidity
- $31.23K
- Best bid
- 1%
- Best ask
- 99%
- Spread
- 98%
- Last trade
- 64%
Outcomes
Market outcomes
Live pricing
Pricing and liquidity
Current bid, ask, midpoint, spread, and market depth for this outcome.
- Best bid
- 1%
- Best ask
- 99%
- Midpoint
- 50%
- Spread
- 98%
- Last trade
- 64%
- Depth
- 740.32 / 30,491.72
Price history
Waiting for price history
History unavailable
Bids
| Price | Size |
|---|---|
| 1% | 18.59 |
| 5% | 10 |
| 6% | 8.33 |
| 10% | 189.5 |
| 50% | 30 |
| 54% | 16.66 |
| 55% | 16.36 |
| 56% | 17.85 |
Asks
| Price | Size |
|---|---|
| 99% | 18,000 |
| 98% | 12.18 |
| 97% | 200 |
| 95% | 6,300 |
| 94% | 2,921 |
| 93% | 306.31 |
| 85% | 1,500 |
| 84% | 661 |
Trades
Recent trades
Latest visible trades for this market.
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?No 36% 20 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 63% 43 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 63% 30 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 63% 19 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 63% 52.31 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?No 36% 6.24 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 65% 44.91 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 65% 25 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 65% 53.12 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?No 13% 28.06 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 93.7% 43.13 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.2B?Yes 87% 19.99 shares